Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (31)

2024

  1. Long or complicated mpox in patients with uncontrolled HIV infection

    Journal of Medical Virology, Vol. 96, Núm. 3

  2. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

    Journal of Clinical Investigation, Vol. 134, Núm. 8

2023

  1. Standards for the Use of Enteral Nutrition in Patients with Diabetes or Stress Hyperglycaemia: Expert Consensus

    Nutrients, Vol. 15, Núm. 23

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  2. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  3. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

    Frontiers in Immunology, Vol. 13

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  2. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

2019

  1. Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

    PLoS ONE, Vol. 14, Núm. 11

2017

  1. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?

    Actas Dermo-Sifiliograficas, Vol. 107, Núm. 9, pp. 709-711

  2. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?

    Actas Dermo-Sifiliograficas, Vol. 107, Núm. 9, pp. 709-711

2014

  1. Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort

    International Journal of Infectious Diseases, Vol. 26, pp. 83-87

  2. The role of accessibility policies and other determinants of health care provision in the initial prognosis of malignant melanoma: A cross-sectional study

    Journal of the American Academy of Dermatology, Vol. 71, Núm. 3, pp. 507-515

2013

  1. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of staphylococcus aureus bacteremia

    Clinical Infectious Diseases, Vol. 57, Núm. 9, pp. 1225-1233

  2. Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: A prospective cohort study

    BMC Infectious Diseases, Vol. 13, Núm. 1

2012

  1. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 1, pp. 472-478

2011

  1. Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document

    Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39

2010

  1. Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 9, pp. 4367-4379